SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

PICCIN, Daniela
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.816
EU - Europa 448
AS - Asia 254
OC - Oceania 1
Totale 2.519
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.813
CN - Cina 195
DE - Germania 139
UA - Ucraina 119
GB - Regno Unito 59
TR - Turchia 52
SE - Svezia 30
FI - Finlandia 28
IT - Italia 28
RU - Federazione Russa 19
BE - Belgio 10
FR - Francia 9
CA - Canada 3
CZ - Repubblica Ceca 2
IE - Irlanda 2
IN - India 2
IR - Iran 2
NL - Olanda 2
AU - Australia 1
BD - Bangladesh 1
KZ - Kazakistan 1
RO - Romania 1
SG - Singapore 1
Totale 2.519
Salva come PNG Salva come JPEG
Città #
Ashburn 344
Woodbridge 277
Fairfield 164
Jacksonville 139
Chandler 131
Houston 129
Ann Arbor 99
Seattle 69
Wilmington 60
Beijing 54
Cambridge 54
Addison 47
Izmir 44
Nanjing 38
Princeton 27
Milan 23
Boardman 21
San Diego 21
Dearborn 16
Shanghai 15
Shenyang 15
Kunming 11
Brussels 10
Guangzhou 8
Hebei 8
Jiaxing 8
Nanchang 8
New York 8
Jinan 7
Changsha 6
Norwalk 6
San Mateo 6
Leawood 5
Mountain View 5
Redwood City 5
Des Moines 4
Falls Church 4
Tappahannock 4
Tianjin 4
Washington 4
Hangzhou 3
Monmouth Junction 3
Montréal 3
Munich 3
Ardabil 2
Augusta 2
Dublin 2
Hefei 2
Helsinki 2
Prescot 2
Taizhou 2
Verona 2
Acton 1
Almaty 1
Bremen 1
Brno 1
Changchun 1
Delhi 1
Dhaka 1
Ferrara 1
Jinhua 1
Kilburn 1
Lappeenranta 1
Mcallen 1
Messina 1
Mumbai 1
Ningbo 1
Paris 1
Philadelphia 1
Yellow Springs 1
Zhengzhou 1
Totale 1.955
Salva come PNG Salva come JPEG
Nome #
SRC homology-2-containing protein tyrosine phosphatase-1 restrains cell proliferation in human medullary thyroid carcinoma 334
Cyclooxygenase-2 inhibitors reverse chemoresistance phenotype in medullary thyroid carcinoma by a permeability glycoprotein-mediated mechanism 141
Selective activation of somatostatin receptor subtypes differentially modulates secretion and viability in human medullary thyroid carcinoma primary cultures: potential clinical perspectives. 136
Pasireotide, a multiple somatostatin receptor subtypes ligand, reduces cell viability in non functioning pituitary adenomas by inhibiting Vascular Endothelial Growth Factor secretion. 132
Cyclooxygenase-2 inhibitors prevent the development of chemoresistance phenotype in a breast cancer cell line by inhibiting glycoprotein p-170 expression. 131
Proteasomes and RARS modulate AIMP1/EMAP II secretion in human cancer cell lines. 114
Somatostatin receptor subtype 1 selective activation reduces cell growth and calcitonin secretion in a human medullary thyroid carcinoma cell line. 109
null 106
miR-15a and miR-16-1 down-regulation in pituitary adenomas 104
Identification of differentially expressed microRNAs by microarray: a possible role for microRNA genes in pituitary adenomas. 101
Somatostatin, but not somatostatin receptor subtypes 2 and 5 selective agonists, inhibits calcitonin secretion and gene expression in the human medullary thyroid carcinoma cell line, TT. 100
An in vivo OctreoScan-negative adrenal pheochromocytoma expresses somatostatin receptors and responds to somatostatin analogs treatment in vitro 98
Somatostatin receptor subtype 1 selective activation in human growth hormone- and prolactin-secreting pituitary adenomas: effects on cell viability, growth hormone and prolactin secretion. 83
Antiproliferative effects of somatostatin analogs in pituitary adenomas 82
SHP-1 restrains cell proliferation in human medullary thyroid carcinoma 82
Role of complex Cdk4/Cyclin D1 in somatostatin subtype 2 receptor-mediated inhibition of cell proliferation of a medullary thyroid carcinoma cell line in vitro 82
Multiple somatostatin receptor subtypes activation reduces cell viability in non-functioning pituitary adenomas by inhibiting Vascular Endothelial Growth Factor secretion 79
Selective Cyclo-oxygenase 2 inhibitors revert chemoresistance In Medullary thyroid carcinoma by a mechanism mediated by P-gp and PGH2 67
Role of complex cyclin D1/Cdk4 in somatostatin subtype 2 receptor-mediated inhibition of cell proliferation of a medullary thyroid carcinoma cell line in vitro 66
Evidence for differential effects of selective somatostatin receptor subtype agonists on alpha-subunit and chromogranin A secretion and on cell viability in human non-functioning pituitary adenomas in vitro 66
Chemoresistance of Medullary thryroid carcinoma cells is reversed by COX-2 inhibitors in vitro through a PGE2-dependent mechanism 65
Somatostatin analogs in vitro effects in a growth hormone-releasing hormone (GHRH)-secreting bronchial carcinoid 63
Somatostatin inhibits a medullary thyroid carcinoma cell line growth by activating SHP-1 62
SSTR subtypes expression pattern influences the antiproliferative effects of somatostatin and lanreotide on human medullary thyroid carinomas in vitro 56
Somatostatin differentially influences proliferation and gene expression by modulating SHP-1 and cAMP pathways in a human medullary thyroid carcinoma cell line 55
Dopamine receptor subtype 2 and somatostatin receptor subtype 5 expression influences somatostatin analogs effects on human somatotroph pituitary adenomas in vitro 18
Totale 2.532
Salva come PNG Salva come JPEG
Categoria #
all - tutte 8.136
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.136
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019221 0 0 0 0 0 0 0 0 0 47 60 114
2019/2020510 76 16 20 61 42 61 43 54 37 54 39 7
2020/2021287 34 29 8 33 12 29 11 32 6 34 49 10
2021/2022330 10 41 31 6 18 12 17 11 10 21 33 120
2022/2023281 28 24 24 35 36 46 24 16 31 1 12 4
2023/2024373 16 28 3 5 12 26 6 273 4 0 0 0
Totale 2.532